These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
436 related items for PubMed ID: 15500714
41. Outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Rossi M, Merli M, Lai Q, Gentili F, Mennini G, Bussotti A, Pugliese F, Della Pietra F, Poli L, Novelli G, Giusto M, Ginanni Corradini S, Iappelli M, Onetti Muda A, Di Tondo U, Gossetti F, Attili AF, Berloco PB. Transplant Proc; 2007; 39(6):1895-7. PubMed ID: 17692646 [Abstract] [Full Text] [Related]
42. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma. Malik SM, Gupte PA, de Vera ME, Ahmad J. Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869 [Abstract] [Full Text] [Related]
45. Hepatocellular carcinoma with bile duct thrombi: analysis of surgical treatment. Peng SY, Wang JW, Liu YB, Cai XJ, Xu B, Deng GL, Li HJ. Hepatogastroenterology; 2004 Jul; 51(57):801-4. PubMed ID: 15143920 [Abstract] [Full Text] [Related]
47. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation. Zou WL, Zang YJ, Chen XG, Shen ZY. Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848 [Abstract] [Full Text] [Related]
49. [Liver transplantation for treating hepatocellular carcinoma]. Liu XD, Yang ZY, Wang SG, Bie P, Zheng SG, Zhang LD, He Y, Lu Q, Yang ZQ, Dong JH. Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):255-7. PubMed ID: 16635291 [Abstract] [Full Text] [Related]
50. Five-year survival after monotherapy for hepatocellular carcinoma in the setting of cirrhosis. Fouzas I, Sotiropoulos GC, Sgourakis G, Drühe N, Wohlschlaeger J, Molmenti EP, Broelsch CE, Lang H. Transplant Proc; 2008 Nov; 40(9):3204-5. PubMed ID: 19010235 [Abstract] [Full Text] [Related]
51. Liver transplantation for hepatocellular carcinoma: expanding special priority to include stage III disease. Goodman J, Glasgow SC, Schnitzler M, Lowell JA, Shenoy S, Jendrisak MD, Desai N, Lisker-Melman M, Crippin J, Chapman WC. Arch Surg; 2005 May; 140(5):459-64; discussion 464. PubMed ID: 15897441 [Abstract] [Full Text] [Related]
53. Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report. Malagó M, Sotiropoulos GC, Nadalin S, Valentin-Gamazo C, Paul A, Lang H, Radtke A, Saner F, Molmenti E, Beckebaum S, Gerken G, Frilling A, Broelsch CE. Liver Transpl; 2006 Jun; 12(6):934-40. PubMed ID: 16528715 [Abstract] [Full Text] [Related]
60. The outcome of surgical resection versus assignment to the liver transplant waiting list for hepatocellular carcinoma. Pierie JP, Muzikansky A, Tanabe KK, Ott MJ. Ann Surg Oncol; 2005 Jul; 12(7):552-60. PubMed ID: 15889217 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]